{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:02:57Z","timestamp":1760043777627},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1093\/jat\/bkx029","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T19:34:43Z","timestamp":1491420883000},"page":"646-657","source":"Crossref","is-referenced-by-count":16,"title":["Metabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine"],"prefix":"10.1093","volume":"41","author":[{"given":"Keith-Dane H.","family":"Temporal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen S.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda L.A.","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry K.","family":"Logan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,5,3]]},"reference":[{"key":"key\n\t\t\t\t20170824054940_bkx029C1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/PAF.0000000000000082","article-title":"Pathological findings in 2 cases of fatal 25I-NBOMe toxicity","volume":"35","year":"2014","journal-title":"The American Journal of Forensic Medicine and Pathology"},{"key":"key\n\t\t\t\t20170824054940_bkx029C2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13181-013-0314-y","article-title":"2-(4-Iodo-2, 5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl] ethanamine (25I-NBOMe): clinical case with unique confirmatory testing","volume":"10","year":"2014","journal-title":"Journal of Medical Toxicology"},{"key":"key\n\t\t\t\t20170824054940_bkx029C3","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.forsciint.2013.10.015","article-title":"Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl] ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death","volume":"234","year":"2014","journal-title":"Forensic Science International"},{"key":"key\n\t\t\t\t20170824054940_bkx029C4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/15563650.2013.772191","article-title":"A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug","volume":"51","year":"2013","journal-title":"Clinical toxicology"},{"key":"key\n\t\t\t\t20170824054940_bkx029C5","first-page":"113","article-title":"2C-I-NBOMe, an \u2018N-bomb\u2019 that kills with \u2018Smiles\u2019. Toxicological and legislative aspects","volume":"38","year":"2014","journal-title":"Drug and Chemical Toxicology"},{"key":"key\n\t\t\t\t20170824054940_bkx029C6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.psym.2014.11.002","article-title":"Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature","volume":"56","year":"2015","journal-title":"Psychosomatics"},{"key":"key\n\t\t\t\t20170824054940_bkx029C7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/jat\/bkw035","article-title":"Detection of 25C-NBOMe in three related cases","volume":"40","year":"2016","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t20170824054940_bkx029C8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/15563650.2015.1115056","article-title":"Case series: toxicity from 25B-NBOMe--a cluster of N-bomb cases","volume":"54","year":"2016","journal-title":"Clinical Toxicology (Philadelphia, PA)"},{"key":"key\n\t\t\t\t20170824054940_bkx029C9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/dta.1865","article-title":"In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS","volume":"8","year":"2016","journal-title":"Drug Testing and Analysis"},{"key":"key\n\t\t\t\t20170824054940_bkx029C10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1021\/acs.chemrestox.5b00450","article-title":"Metabolic fate of hallucinogenic NBOMes","volume":"29","year":"2016","journal-title":"Chemical Research in Toxicology"},{"key":"key\n\t\t\t\t20170824054940_bkx029C11","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1007\/s00216-015-8828-6","article-title":"Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MSn, and LC-HR-MS\/MS","volume":"407","year":"2015","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"key\n\t\t\t\t20170824054940_bkx029C12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/jat\/bkv079","article-title":"Identification of metabolite biomarkers of the designer hallucinogen 25I-NBOMe in mouse hepatic microsomal preparations and human urine samples associated with clinical intoxication","volume":"39","year":"2015","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t20170824054940_bkx029C13","first-page":"2016","article-title":"Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH","year":"2016","journal-title":"Drug Testing and Analysis"},{"key":"key\n\t\t\t\t20170824054940_bkx029C14","article-title":"25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry","year":"2016","journal-title":"Drug Testing and Analysis"},{"key":"key\n\t\t\t\t20170824054940_bkx029C15","year":"2004"},{"key":"key\n\t\t\t\t20170824054940_bkx029C16","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/0269881114523866","article-title":"The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample","volume":"28","year":"2014","journal-title":"Journal of Psychopharmacology"},{"key":"key\n\t\t\t\t20170824054940_bkx029C17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2013.08.025","article-title":"Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response","volume":"77","year":"2014","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t20170824054940_bkx029C18","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1124\/mol.106.028720","article-title":"Molecular interaction of Serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists","volume":"70","year":"2006","journal-title":"Molecular Pharmacology"},{"key":"key\n\t\t\t\t20170824054940_bkx029C19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/10550887.2014.950027","article-title":"NBOMe designer drug exposures reported to Texas poison centers","volume":"33","year":"2014","journal-title":"Journal of Addictive Diseases"},{"key":"key\n\t\t\t\t20170824054940_bkx029C20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/15563650.2014.909932","article-title":"Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe","volume":"52","year":"2014","journal-title":"Clinical Toxicology"},{"key":"key\n\t\t\t\t20170824054940_bkx029C21","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/qua.20256","article-title":"A study of ring-substitutent influence on pharmacological activity in a series of phenethylamin-type psychadelics","volume":"100","year":"2004","journal-title":"International Journal of Quantum Chemistry"},{"key":"key\n\t\t\t\t20170824054940_bkx029C22"},{"key":"key\n\t\t\t\t20170824054940_bkx029C23","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/cmdc.200800133","article-title":"Structure\u2013activity relationships of phenylalkylamines as agonist ligands for 5-HT2A receptors","volume":"3","year":"2008","journal-title":"ChemMedChem"},{"key":"key\n\t\t\t\t20170824054940_bkx029C24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0041-008X(03)00128-5","article-title":"An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons","volume":"189","year":"2003","journal-title":"Toxicology and Applied Pharmacology"},{"key":"key\n\t\t\t\t20170824054940_bkx029C25","year":"2015"},{"key":"key\n\t\t\t\t20170824054940_bkx029C26"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/41\/7\/646\/19593609\/bkx029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T07:12:30Z","timestamp":1503645150000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jat\/article\/41\/7\/646\/3793129\/Metabolic-Profile-Determination-of-NBOMe-Compounds"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,3]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,5,3]]},"published-print":{"date-parts":[[2017,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkx029","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,3]]}}}